MONDAY, 30 June
Program subject to change.
| 6:40 - 7:40 | EACPT early morning
activities (run, walk or yoga) | ||||||
| Details to be announced EACPT2025 Chair Janne Backman, University of Helsinki, Helsinki, Finland, and EACPT President Gerard Rongen, University of Nijmegen, Nijmegen, the Netherlands | ||||||
| 8:20 - 9:00 | Keynote Lecture 2 | ||||||
| Chair: Outi Lapatto-Reiniluoto, Helsinki University Hospital, Helsinki, Finland Climate Change and its Health Dimensions Petteri Taalas, Director General, Finnish Meteorological Institute | ||||||
| 9:00 - 10:30 | Concurrent Sessions | |||||
| Session A3: Societal perspective of pharmacotherapy Chairs: Katri Hämeen-Anttila, University of Eastern Finland, Kuopio, Finland and Martin Fromm, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany | |||||
| 9:00 - 9:30 | Policies and strategies to enhance uptake of biosimilars Dorthe Barthels, Amgros I/S, Copenhagen, Denmark | ||||
| 9:30 - 10:00 | Financial burden of medicines for patients Katri Aaltonen, University of Turku, Turku, Finland | ||||
| 10:00 - 10:30 | Short oral presentations - To be announced | ||||
| Session B4: Drug development beyond the era of small molecules Chairs: Katriina Vuolteenaho, Tampere University, Tampere, Finland and Carolina Säll, Novo Nordisk, Copenhagen, Denmark | |||||
| 9:00 - 9:30 | Reflections on two decades of oligo ADME development Steve Hood, GSK, Stevenage, United Kingdom | ||||
| 9:30 - 10:00 | Can we utilize a small molecule strategy when developing therapeutic peptides? Carolina Säll, Novo Nordisk, Copenhagen, Denmark | ||||
| 10:00 - 10:30 | Short oral presentations - To be announced | ||||
| Session C4: Neurodegenerative diseases Chairs: Mikko Airavaara, University of Helsinki, Helsinki, Finland and Dominique Deplanque, University of Lille, Lille, France | |||||
| 9:00 - 9:30 | Intra-cerebral administration of an anaerobic form of dopamine in Parkinson's disease: from experimental models to clinical development David Devos, University of Lille, Lille, France | ||||
| 9:30 - 10:00 | Parkinson's disease subtypes - does it impact pharmacological management? Filip Scheperjans, University of Helsinki, Helsinki, Finland | ||||
| 10:00 - 10:30 | Short oral presentations - To be announced | ||||
| 10:30 - 11:00 | Refreshment Break | |||||
| 11:00 - 12:30 | Concurrent Sessions | |||||
| Session A4: TDM: benefits and limitations Chairs: Erik Eliasson, Karolinska Institutet, Stockholm, Sweden and Pierre Marquet, University of Limoges, Limoges, France | |||||
| 11:00 - 11:30 | The value of mycophenolate mofetil therapeutic drug monitoring for kidney transplant patients Pierre Marquet University of Limoges, Limoges, France | ||||
| 11:30 - 12:00 | Antimicrobial TDM in the critically ill Jason Roberts, University of Queensland, Brisbane, Australia | ||||
| 12:00 - 12:30 | Short oral presentations - To be announced | ||||
| Session B5: Addressing unmet needs Chairs: Timo Myöhänen, University of Helsinki, Helsinki, Finland and Caridad Pontes, Universitat Autónoma de Barcelona, Barcelona, Spain | |||||
| 11:00 - 11:30 | Making rare disease treatments less rare Tina Taube, EFPIA, Brussels, Belgium | ||||
| 11:30 - 12:00 | Model-informed drug development for rare diseases Piet van der Graaf, University of Leiden, The Netherlands | ||||
| 12:00 - 12:30 | Short oral presentations - To be announced | ||||
| Session C5: Chronic pulmonary diseases Chairs: Jukka Mäenpää, Astra Zeneca, Gothenburg, Sweden and Clive Page, King's College London, London, United Kingdom | |||||
| 11:00 - 11:30 | Disease modifying treatments in early COPD Rod Hughes, AstraZeneca, Cambridge, United Kingdom | ||||
| 11:30 - 12:00 | Emerging drug targets in chronic pulmonary disease Clive Page, King's College London, London, United Kingdom | ||||
| 12:00 - 12:30 | Short oral presentations - To be announced | ||||
| 12:30 - 14:00 | Lunch and Poster Viewing | |||||
| 14:00 - 15:30 pm | Concurrent Sessions | |||||
| Industry Sponsored Session A5: Medbase Symposium - Decision support tools in pharmacotherapy (preliminary program) Chairs: Maija Kaukonen, Medbase, Turku, Finland and Kari Laine, Medbase, Turku, Finland | |||||
| 14:00 - 14:30 | Decision support systems in optimizing pharmacotherapy: Evidence, challenges, and future directions Speaker to be announced | ||||
| 14:30 - 15:00 | Decision support in practice: population and patient level potential Speaker to be announced | ||||
| 15:00 - 15:20 | Medbase solutions for decision-making tools in pharmacotherapy Speaker to be announced | ||||
| 15:20 - 15:30 | Short oral presentation - Speaker to be announced | ||||
| Session B6: ADME biomarkers and extracellular vesicles: Phenotyping of drug metabolism, transport, and interactions Chairs: Anne Filppula, Åbo Akademi University, Turku, Finland and Julia Stingl, Uniklinik RWTH Aachen, Aachen, Germany | |||||
| 14:00 - 14:30 | Application of endogenous biomarkers and liquid biopsy in patients with renal impairment Alexandra Galetin, University of Manchester, Manchester, United Kingdom | ||||
| 14:30 - 15:00 | Phenotyping with biomarkers to model drug interactions Julia Stingl, Uniklinik RWTH Aachen, Aachen, Germany | ||||
| 15:00 - 15:30 | Short oral presentations - To be announced | ||||
| Session C6: Vascular diseases Chairs: Virpi Talman, University of Turku, Turku, Finland and Gerard Rongen, Radboud University Medical Center, Nijmegen, the Netherlands | |||||
| 14:00 - 14:30 | Lipid-lowering therapies - what is on the horizon for triglycerides and Lp(a)? Giuseppe Danilo Norata, University of Milan, Milan, Italy | ||||
| 14:30 - 15:00 | Is there a holy grail of anticoagulation without increased bleeding? Riitta Lassila, University of Helsinki, Helsinki, Finland | ||||
| 15:00 - 15:30 | Short oral presentations - To be announced | ||||
| 15:30 - 16:00 | Refreshment Break | |||||
| 16:00 - 17:00 | EACPT General Assembly Chairs: EACPT Chairperson Gerard Rongen, University of Nijmegen, Nijmegen, the Netherlands and EACPT Chairperson-elect Janne Backman, University of Helsinki, Helsinki, Finland Details to be announced | |||||
| 17:00 - 18:30 | Concurrent Sessions | |||||
| Panel discussion 1 - Program to be announced | ||||||
| EASLDHILI & IUPHAR Session B7: Drug induced liver injury - Current topics Chairs: Caroline Samer, University of Geneva, Geneva, Switzerland and M Isabel Lucena, University of Malaga, Malaga, Spain | ||||||
| 17:00 - 17:30 | Pharmacogenomics in DILI: A pathway to personalized precision medicine Ann Daly, University of Newcastle, Newcastle, United Kingdom | |||||
| 17:30 - 18:00 | Design, endpoints and challenges in conducting randomized clinical trials in DILI Jimin Mao, Shanghai Jiao Tong University, Shanghai, China | |||||
| 18:00 - 18:30 | Short oral presentations - To be announced | |||||
| Education symposium 2 (Education Working Group) Chairs: Joost Piët, Amsterdam UMC, Amsterdam, the Netherlands | ||||||
| 17:00 - 17:30 | EU Project reporting - Speakers to be announced | |||||
| 17:30 - 18:30 | Clinical Pharmacology and Therapeutics Teach the
Teacher (CP4T) workshop: How to set up a student-assistant system for CPT education Joost Piët | |||||
| 17:00 pm - 18:30 pm | EACPT Council Meeting (for Councillors only) | ||||||
| 18:30 pm - 19:30 pm | Free time | ||||||
| 19:30 pm - | EACPT Congress Dinner (separate ticket required) | ||||||